Skip to content

Three wound-dressing strategies to reduce surgical site infection after abdominal surgery: the Bluebelle feasibility study and pilot RCT

Research output: Contribution to journalArticle

Original languageEnglish
Number of pages204
JournalHealth Technology Assessment
Volume23
Issue number39
DOIs
DateAccepted/In press - 1 Mar 2018
DatePublished (current) - 1 Aug 2019

Abstract

Background
Surgical site infection (SSI) affects up to 20% of people with a primary closed wound after surgery. Wound dressings may reduce SSI.
Objective
To assess the feasibility of a multicentre randomised controlled trial (RCT) to evaluate the effectiveness and cost-effectiveness of dressing types or no dressing to reduce SSI in primary surgical wounds.
DesignPhase A – semistructured interviews, outcome measure development, practice survey, literature reviews and value-of-information analysis. 
Phase B – pilot RCT with qualitative research and questionnaire validation. Patients and the public were involved.SettingUsual NHS care.ParticipantsPatients undergoing elective/non-elective abdominal surgery, including caesarean section.
Interventions
Phase A – none. 
Phase B – simple dressing, glue-as-a-dressing (tissue adhesive) or ‘no dressing’.

Main outcome measures
Phase A – pilot RCT design; SSI, patient experience and wound management questionnaires; dressing practices; and value-of-information of a RCT. 
Phase B – participants screened, proportions consented/randomised; acceptability of interventions; adherence; retention; validity and reliability of SSI measure; and cost drivers.
Data sources
Phase A – interviews with patients and health-care professionals (HCPs), narrative data from published RCTs and data about dressing practices. 
Phase B – participants and HCPs in five hospitals.
Results
Phase A – we interviewed 102 participants. HCPs interpreted ‘dressing’ variably and reported using available products. HCPs suggested practical/clinical reasons for dressing use, acknowledged the weak evidence base and felt that a RCT including a ‘no dressing’ group was acceptable. A survey showed that 68% of 1769 wounds (727 participants) had simple dressings and 27% had glue-as-a-dressing. Dressings were used similarly in elective and non-elective surgery. The SSI questionnaire was developed from a content analysis of existing SSI tools and interviews, yielding 19 domains and 16 items. A main RCT would be valuable to the NHS at a willingness to pay of £20,000 per quality-adjusted life-year. 
Phase B – from 4 March 2016 to 30 November 2016, we approached 862 patients for the pilot RCT; 81.1% were eligible, 59.4% consented and 394 were randomised (simple, n = 133; glue, n = 129; no dressing, n = 132); non-adherence was 3 out of 133, 8 out of 129 and 20 out of 132, respectively. SSI occurred in 51 out of 281 participants. We interviewed 55 participants. All dressing strategies were acceptable to stakeholders, with no indication that adherence was problematic. Adherence aids and patients’ understanding of their allocated dressing appeared to be key. The SSI questionnaire response rate overall was 67.2%. Items in the SSI questionnaire fitted a single scale, which had good reliability (test–retest and Cronbach’s alpha of > 0.7) and diagnostic accuracy (c-statistic = 0.906). The key cost drivers were hospital appointments, dressings and redressings, use of new medicines and primary care appointments.
Limitations
Multiple activities, often in parallel, were challenging to co-ordinate. An amendment took 4 months, restricting recruitment to the pilot RCT. Only 67% of participants completed the SSI questionnaire. We could not implement photography in theatres.
Conclusions
A main RCT of dressing strategies is feasible and would be valuable to the NHS. The SSI questionnaire is sufficiently accurate to be used as the primary outcome. A main trial with three groups (as in the pilot) would be valuable to the NHS, using a primary outcome of SSI at discharge and patient-reported SSI symptoms at 4–8 weeks.
Trial registration
Phase A – Current Controlled Trials ISRCTN06792113; 
Phase B – Current Controlled Trials ISRCTN49328913.
Funding
This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 23, No. 39. See the NIHR Journals Library website for further project information. Funding was also provided by the Medical Research Council ConDuCT-II Hub (reference number MR/K025643/1).

    Research areas

  • Feasibility study, wound dressings, surgery, surgical site infection, pilot randomised controlled trial, qualitative research, value of information

    Structured keywords

  • Centre for Surgical Research

Download statistics

No data available

Documents

Documents

  • Full-text PDF (final published version)

    Rights statement: This is the final published version of the article (version of record). It first appeared online via NIHR at https://www.journalslibrary.nihr.ac.uk/hta/hta23390#/abstract. Please refer to any applicable terms of use of the publisher.

    Final published version, 8 MB, PDF document

    Licence: Other

DOI

View research connections

Related faculties, schools or groups